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Summary: In preventive studies of Company employees in Westphalia, HDL cholesterol was measured in the
sera of 4933 men and 2365 women, äs well äs HDL apolipoprotein A-I in the sera of 3509 men and 1648
women. Three subgroups were compared:
non-smokers = persons who have never smoked;
ex-smokers = persons who do not smoke ät present but did in the past;
smokers = persons who sinoke cigarettes at present.
Mean values for HDL cholesterol and for HDL apolipoprotein A-I were significantly lower in smokers than in
non-smokers or in ex-smokers, while there were no differences between the last two groups. These differences
appeared in both sexes but were more pronounced in women than in men. To answer the question whether
the observed differences are caused by the consumption of cigarettes by itself or whether they are caused by
the presence of othef risk factors, further subgroups were compared to assess the influence of the risk factors
obesity, hypertension, hypercholesterolaemia, hyperglycaemia and hyperuricaemia. It was found that — re-
gardless of the presence of no, one, two or more risk factors — the frequency of probands with low HDL
cholesterpl values (<0.907 mmöl/1 (men); < 1.166 mmol/1 (women)) was about 10% higher in smokers than
in non-smokers or ex-smokers. Subgroups based on the number of risk factors did not exhibit the same clear
distribution for apolipoprotein A-I values äs were seen for HDL cholesterol.
The results are interpreted in the light of the existing literature.
Einfluß des Zigarettenrauchens auf die Konzentration von HDL-Cholesterin und HDL-Apolipoprotein A-I im
Blutserum - Ergebnisse der prospektiven epidemiologischen Studie bei Betriebsangehörigen in Westfalen
Zusammenfassung: Im Rahmen präventiver Untersuchungen bei Betriebsangehörigen in Westfalen wurden
bei 4933 Männern und 2365 Frauen die HDL-Cholesterinwerte und bei 3509 Männern und 1648 Frauen
zusätzlich die HDL-Apolipoprotein A-I-Werte im Blutserum bestimmt. Drei Untergruppen wurden mit-
einander verglichen:
Nichtraucher = Personen, die niemals geraucht hatten;
Ex-Raucher = Personen, die zur Zeit nicht rauchten, aber früher geraucht hatten;
Raucher = Personen, die zur Zeit Zigaretten rauchten.
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Sowohl die HDL-Cholesterin- als auch die HDL-Apolipoprotein A-I-Werte waren bei Rauchern signifikant
niedriger als bei Nichtrauchern oder Ex-Rauchern, während zwischen den beiden letzteren Gruppen kein
Unterschied bestand. Die Unterschiede waren bei beiden Geschlechtern vorhanden, bei Frauen jedoch
deutlicher als bei Männern ausgeprägt. Zur Beantwortung der Frage, ob die beobachteten Differenzen durch
das Zigarettenrauchen selbst oder durch das Vorliegen weiterer Risikofaktoren hervorgerufen wurden,
wurden unter Berücksichtigung der Risikofaktoren Übergewicht, Bluthochdruck, Hyperglykämie und
Hyperurikämie weitere Untergruppen miteinander verglichen. Es wurde gefunden, daß - unabhängig ob
kein, ein oder mehrere Risikofaktoren vorlagen - die Häufigkeit von Probanden mit niedrigen HDL-
Cholesterinwerten (< 0,907 mmol/1 (Männer), < 1,166 mmol/1 (Frauen)) bei Rauchern etwa 10% höher als
bei Nichtrauchern oder Ex-Rauchern lag. In den nach der Anzahl der Risikofaktoren aufgeteilten Unter-
gruppen konnte nicht die gleiche klare Verteilung der Lipoprotein A-I-Werte gezeigt werden wie beim HDL-
Cholesterin.
Die Ergebnisse werden unter Berücksichtigung der Literatur diskutiert.
Introduction
Serum HDL cholesterol has been measured increas-
ingly in recent years, due to the fact that there is an
apparent negative correlation of HDL cholesterol
level and coronary risk (1-4). It has been demon-
strated in various epidemiological studies that ciga-
rette smokers have lower HDL cholesterol levels
than non-smokers or ex-smokers (5-14). On the
other hand, there has been little research to date on
the potential effects of other components of HDL
(e. g. apolipoprotein A-I, apolipoprotein A-II, phos-
phatidyl choline, sphingomyelin).
This is a report on the findings of epidemiological
studies (15) on the effect of cigarette smoking on
HDL cholesterol and HDL apolipoprotein A-I.
Materials and Methods
A total of 4935 male and 2365 female employees of four different
companies in Westphalia were examined in the course of our
prospective study of Company employees. Twelve-hour fasting
blood samples were taken in the mornings in a specially equipped
bus, and were allowed to stand for 30 minutes at room tempera-
ture. Serum was obtained by centrifugation at 3000 min"1, stored
at 4 °C and transported to our laboratories within a maximum of
three days. The assays were carried out within 24 hours of receiv-
ing the samples.
For evaluation purposes, participants in the study were divided
into three subgroups, äs follows:
1. non-smokers = individuals who had never smoked before;
2. ex-smokers = individuals who did not smoke at the time, but
had been smokers in the past;
3. smokers = individuals who smoked eigarettes at the time
of the study.
HDL fractions were assayed in the supernatant using the Boehrin-
ger Mannheim test (no. 400971) following precipitation of apo·-
lipoprotein B^containing lipoproteins by means of phosphotung-
stic acid/MgCh. HDL cholesterol was enzymatically determined
using the CHOD-PAP method (Boehringer Mannheim, combina-
tion test no. 187313). HDL apolipoprotein A-I was assayed by
kinetic nephelometry, äs described in detail elsewhere (16).
Results were statistically evaluated using the 2 test or the Krus-
kal-Wallis test, and by multiple comparison of independent sam-
ples by the method of Nemenyi or Duncan. The significance level
was set at p <0.05.
Results
The effect of cigarette smoking on HDL cholesterol
levels
HDL cholesterol values were distributed log^nor-
mally in the total group äs well äs in all considered
subgroups.
In smokers the HDL cholesterol level was signifi-
cantly lower than in non-smokers and ex-smokers al-
though no sigriificant differences were observed be-
tween non-smokers and ex-smokers (tab. 1). The
disparity was apparent in both sexes, being some-
what more pronounced in women than in men. The
Proportion of probands with reduced HDL chöleste-
rol (< 0.907 mmol/1 in men, < 1.166 mmol/1 in
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women) was markedly higher among smokers (by a
factor of 1.5) than among the non-smokers or ex-
smokers (p < 0.01 at least) (tab. 2).
For the purpose of determining whether the ob-
served differences were solely attributable to ciga-
rette smoking or whether collateral risk factors were
involved, probands were divided into three sub-
groups on the basis of the risk factors listed in
table 3. The three groups consisted of probands ex-
hibiting no other risk factor, those with exactly one
additional risk factor, and those with two or more
additional risk factors. If only the number of risk fac-
tors is considered, it is apparent that the differences
between non-smokers and ex-smokers on the one
hand and smokers on the other hand remain evident
in each of the three subgroups (tab. 4). It was
markedly apparent among men that the frequency
< 0.907 mmol/1 was approximately 10% higher in
each case among smokers than among non-smokers
or ex-smokers, regardless of whether there were ad-
ditional risk factors involved or not. Among women
this difference was evident only when there were no
additional or only one additional risk factor present;
in cases involving two or more additional risk factors
there were no differences observed between female
smokers and non-smokers in the group of probands
with HDL cholesterol values < 1.166 mmol/1. It
Tab. 2. Frequency of probands with reduced serum HDL cho-







14.3% (n = 1550)
15.2% (n = 1288)
22.7% (n = 2097)
18.1% (n = 4935)
Women
22.4% (n = 1346)
22.2% (n = 252)
32.5% (n = 767)
25.6% (n = 2365)
Comparisons: men: Non-Smokers/Ex^Smokers, n. s.,
Non^Smokers/Smokers p < 0.001
Ex-Smpkers/Smokers p < 0.001
women: Non^Smokers/Ex-Smokers, n.s.,
Non-Smokers/Smokeis p < 0.001
Ex-Smokers/Smokers p < 0.01








Broca index > = 110%
Blood pressure > = 160/95 mm Hg
Serum cholesterol > = 6.734 mmol/1
Serum triglycerides > = 2.28 mmol/1
Serum glucose > = 7.215 mmol/1
Serum uric acid > = 475.9 μηιοΐ/l
(men)
or > = 446.1μπιο1/1
(women)
must, however, be taken into account that the
number of probands involved was relatively small
(22 ex-smokers and 72 smokers).
Tab. 4. Frequency of probands with reduced serum HDL choles-
terol (<0.907 mmol/1 in men, < 1.166 mmol/1 in women)
























































































p < 0.05 p < 0.001
p<0.01 p<0.01
Women
p < 0.001 p < 0.05
p < 0.05 p < 0.05
n. s. n. s.
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In order to determine whether the number of ciga-
rettes smoked every day influences serum levels of
HDL cholesterol, the probands were divided into
three groups comprising non-smokers, smokers who
smoked up to an average of 20 cigarettes a day, and
smokers who smoked more than 20 cigarettes a day.
Significant differences were apparent in both men
and women between non-smokers on the one hand
and moderate and heavy smokers on the other, but
not between the two groups of smokers (tab. 5).
Evaluation of other subgroups divided on the basis
of daily cigarette consumption showed that there
were no disparities in HDL cholesterol levels be-
tween non-smokers and very light smokers (up to 5
cigarettes a day), whereas above 5 cigarettes a day
the reduced HDL cholesterol values previously de-
scribed were again apparent. The degree of serum
HDL cholestrol reduction was not influenced by the
number of cigarettes smoked per day.
Since the mean values of age were different in non-
smokers (36.0 ± 11.5 in men, 37.3 ± 12.6 in wom-
en), ex-smokers (41.7 ± 11.4 in men, 33.1 ± 12.6 in
women) and smokers (37.3 ± 11.2 in men, 32.0 +
11.5 in women) and risk factors are highly correlated
with age, the computations were repeated for age-
tertiles (under 35, 35-45, over 45 years of age) to
eliminate the influence of age.
The findings in the age-tertiles do not differ from
those in the total group with respect of differences
between smokers, non-smokers and ex-smokers but
only with respect to the level of mean values ob-
tained. Therefore, these findings are not presented
in detail.
The effect of smoking on serum level of apolipopro-
tein A-1
Apolipoprotein A-I values were also observed to be
significantly lowerin smokers than in non-smokers or
ex-smokers, though no clear-cut differences were
detected between the latter two groups (tab. 6). The
differences observed were more marked among
women than men. Subgroups based on the number
of risk factors present (tab. 3) did not exhibit the
same clear distribution for apolipoprotein A-I values
äs were seen for HDL cholesterol (tab. 7). The fe-
male smokers with no additional or only one addi-
tional risk factor, and the male smokers exhibiting
exactly one risk factor, showed HDL apolipoprotein
A-I values lower than those of non-smokers and
smokers. No statistical difference was evident, how-
ever, between male non-smokers and smokers in the
subgroup exhibiting no additional risk factors, or be-
tween non-smokers and smokers of both sexes with
Tab. 5. Serum HDL cholesterol levels (rrimol/1) (x ± S.D.) äs i
function of cigarette consumption.
Men Women
Non-Smokers at present
1 -20 cigarettes per day



























1-20 cigarettes per day p < 0.001 p < 0.001
Non-Smokers/
> 20 cigarettes per day p < 0.05 p < 0.01
1—20 cigarettes per day/
>20 cigarettes per day n.s. n. s.




















































two or more additional risk factors. As seen in table
8, there were no appajrent differencäs in HDL apo-
lipoprotein A-I values between moderate (1—20
cigarettes/day) and heavy (>20 cigarettes/day)
0 smokers. Fürthermore, no differences were apparent
even when smokers were furffier evalüated on the» »
basis of daily cigarette consumption.
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Tab. 7. Mean values and Standard deviations of serum apolipo-
protein A-I levels (g/l) s a function of cigarette con-






















































































































Tab. 8. Serum apolipoprotein A-I levels (g/l) (χ ± S.D.) s a
function of cigarette consumption.
Men Women
Non-Smokers at present χ 1.382 1.501
±0.222 ±0.243
n 1917 1.089
1 -20 cigarettes per day χ 1.346 1.420
±0.229 ±0.257
n 1221 485






1 -20 cigarettes per day p < 0.00 1 p < 0.00 1
Non-Smokers/
> 20 cigarettes per day p < 0.05 n.s.
1 -20 cigarettes per day/
> 20 cigarettes per day n.s. n.s.
Since HDL apolipoprotein A-I values in both sexes
show a correlation with age, the additional influence
of age has been eliminated by repeating the evalua-
tions detailed here for various age groups (under 35,
35—45, and over 45 years of age). The findings do
not indicate any age-related influence on the reduc-
tion in apolipoprotein A-I concentration observed in
conjunction with cigarette smoking.
Discussion
A nuinber of epidemiological studies (8 10,
12^14) indicate that smokers have significantly low-
er levels of HDL cholesterol than non-smokers (dif-
ferences of approx. 0.078-0.130 mmol/1 in men,
0.130—0.181 mmol/1 in women). Our epidemiologi-
cal findings, conducted on 4935 male and 2365 fe-
male employees of companies in Westphalia, West
Germany, concur with previously published findings.
It has been repeatedly observed that the reduction in
serum HDL cholesterol level is a function of the
number of cigarettes smoked per day (5, 6, 9—14).
However, our study was not able to establish any sig-
nificant differences between the HDL cholesterol
values for moderate (<20/day) and heavy (>20/
day) smokers, among either men or women. The
negative effect of cigarette smoking becomes more
apparent when considered in conjunction with other
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factors influencing HDL cholesterol level, such äs al-
cohol consumption (8, 12, 14), use of oral contra-
ceptives (9, 11, 14), or physical exercise (7, 17).
Our own studies show that the differences in HDL
cholesterol values between smokers and non-smok-
ers are not attributable to collateral risk factors such
äs obesity, hypertension, hypercholesterolaemia, hy-
pertriglyceridaemia, hyperglycaemia, and hyperuri-
caemia. This is an indication that cigarette smoking
in itself leads to a reduction in HDL cholesterol lev-
el. This assumption is further supported by the ob-
servation of other authors (8, 10) äs well äs our own
observations that there are no differences in HDL
cholesterol levels between ex-smokers and non-
smokers, and that smokers who quit show an in-
crease in HDL cholesterol level in the space of a few
weeks (18). It cannot be precluded, however, that
this rise in HDL cholesterol Tievel is due to the in-
crease in caloric intake, particularly in the form of
fat, which is associated with quitting (18).
Certainly the question of the relevance of the ob-
served effects of cigarette smoking on HDL choles-
terol levels is of considerable practical importance.
In this regard, it must be borne in mind that the ef-
fect of smoking on HDL cholesterol is relatively mi-
nor. It must be further taken into consideration that
HDL represents a heterogenous group of macro-
molecules which differ in particle size, chemical
composition, and physicocheinical properties.
Therefore, it is impossible to determine HDL mass
on the basis of HDL cholesterol level and vice versa,
particularly in view of the fact that the cholesterol
content of HDL varies to between 10 and 20% of
the HDL mass. It is in this regard that assaying other
components of HDL such äs HDL apolipoprotein
A-I and HDL phospholipid öffers additional valua-
ble Information.
It is interesting to note that HDL apolipoprotein A-I
values also appear to be lower in smokers than in
non-smokers. The differences in HDL apolipopro-
tein A-I values observed in our study between smok-
ers and non-smokers were, however, in terms of per-
cent, smaller than the differences observed in HDL
cholesterol values. This finding is consistent with the
results reported by other authors (12, 14, 18). Ac-
cording to studies by Dedonder-Decoopman et al.
(12) the drop in apolipoprotein A-I values also ap-
pears to be dependent on the nümber of cigarettes
smoked per day. Our studies, however, were not
able to establish any significant differences between
moderate (<20/day) and heavy (>20/day) smok-
ers.
The epidemiological data presented here leave un-
answered the question of the effects of smoking on
the metabolism of HDL or any of its components.
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